Class certification was denied — again — in litigation brought by plaintiffs who allege a drug maker misstated the likelihood of withdrawal symptoms
Continue Reading Drug Class Action Rejected Again
Mass Tort Defense
Defense of Mass Tort Claims, Class Actions, and Significant Product-Based Litigation